ChromoGenics AB (publ) informs the shareholder list after the registration of the rights issue at the Swedish Companies Registration Office (Bolagsverket) at February 21, 2018.
Shareholder list from Euroclear per February 28, 2018 shows the following ten largest shareholders:
|Shareholder per 2018-02-28||Ordinary shares||Votes and capital|
|K-SVETS VENTURE AB||5 112 350||12,1%|
|NEW ENERGY SOLUTIONS II K/S||4 606 746||10,9%|
|DANSKE BANK INTERNATIONAL S.A.||1 551 225||3,7%|
|FORMUE NORD MARKEDSNEUTRAL A/S||1 374 661||3,3%|
|ULTI AB||1 296 665||3,1%|
|FÖRSÄKRINGSAKTIEBOLAGET, AVANZA PENSION||1 254 334||3,0%|
|LMK FORWARD AB||1 251 226||3,0%|
|NORDNET PENSIONSFÖRSÄKRING AB||1 174 318||2,8%|
|CASTAB AB||709 110||1,7%|
|BENGT JOSEFSSON UTVECKLING AB||570 000||1,4%|
|ÖVRIGA||23 288 360||55,2%|
|TOTAL||42 188 995||100,0%|
Källa: Euroclear AB
Thomas Almesjö, CEO
Susanne Andersson, CFO and Head of Communications
Tel: +46 (0)18 430 0430
ChromoGenics offers dynamic glass with controllable heat- and light transmission. The company’s unique technology ConverLight® provides sustainable solar control for increased indoor comfort and energy efficiency. ConverLight® also contributes to Green Building certifications. In 2016 the company started commercial sales to real estate projects in Scandinavia.
ChromoGenics is located in Uppsala, Sweden, and the technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser.